Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06790160 · ClinicalTrials.gov registry record
Study of Patients Being Treated With Anti-obesity Medication
A clinical trial of Obesity and Overweight, sponsored by Texas Tech University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06790160: Recruiting study of Obesity and Overweight, sponsored by Texas Tech University.
NCT06790160 is a study of Obesity and Overweight that is actively recruiting participants, run by Texas Tech University. The registered enrollment target is 100 participants, below the 462-participant average among 27 other Obesity and Overweight trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06790160, a study of Obesity and Overweight, is actively recruiting participants, sponsored by Texas Tech University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about the real-world effects of selected obesity medications in adults undergoing medical weight management. The main outcomes of interest are changes in body composition, routine clinical markers, muscular performance, and nutritional intake over the course of treatment. Additionally, the influence of lifestyle factors on changes in these outcome variables will be examined. Participants beginning treatment with selected obesity medications will undergo periodic body composition and muscular performance testing, as well as complete online surveys about their nutritional intake and physical activity and exercise participation. Additionally, routinely collected clinical information will be evaluated.
Primary Outcome
Change in total lean soft tissue assessed by dual-energy X-ray absorptiometry.
Conditions Studied
Study Locations (1)
Texas
- Texas Tech University - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-01-31 |
| Est. Completion | 2027-02 |
What NCT06790160 shows while recruiting
NCT06790160 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 462-participant average among 27 other Obesity and Overweight trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Obesity and Overweight appearing as the primary indexed condition, and to 0 interventions.
NCT06790160 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06790160 about?
NCT06790160 is a clinical study titled "Study of Patients Being Treated With Anti-obesity Medication". The goal of this observational study is to learn about the real-world effects of selected obesity medications in adults undergoing medical weight management. The main outcomes of interest are changes in body composition, routine clinical markers, muscular performance, and nutritional intake over the...
What is the current status of trial NCT06790160?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-01-31. Estimated completion is 2027-02.
What conditions does trial NCT06790160 study?
This clinical trial studies the following conditions: Obesity and Overweight.
Who is sponsoring clinical trial NCT06790160?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06790160 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity and Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06790160's enrollment target sits among peer trials
100 11th of 27 higher than 17 of 27 other Obesity and Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity and Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
A Phase 1 Study of WVE-007 in Adults Living With Overweight or Obesity
RECRUITING · Phase 1
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
RECRUITING · Phase 3
-
New Mechanisms of Obesity
RECRUITING · NA
-
Weight Management Intervention in College: A Pilot
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI